Axios | September 13, 2023
Between the lines: The government forcefully pushed back on drug companies’ arguments they are being forced to participate in negotiations because the terms of refusing to do so would be untenable, Zachary Baron, a health care law expert at Georgetown University’s O’Neill Institute, told Axios.